Seres Therapeutics (MCRB) FCF Margin (2016 - 2026)
Seres Therapeutics (MCRB) posted FCF Margin of 4569.83% for Q1 2026, down 35.8% sequentially from 3365.07% in Q4 2025.
Seres Therapeutics (MCRB) FCF Margin (2016 - 2026) Analysis & Trends
Seres Therapeutics has reported FCF Margin for 10 years, with the latest figure at 4569.83% in Q1 2026.
- Quarterly FCF Margin changed N/A year-over-year to 4569.83% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 3692.24% (changed N/A YoY) and the FY2025 annual result came in at 109.63%, changed N/A from the prior year.
- FCF Margin declined to 4569.83% in Q1 2026 per MCRB's latest filing, from 3365.07% in the prior quarter.
- Over five years, FCF Margin peaked at 626.21% in Q3 2025 and troughed at 17523.87% in Q3 2023.
- A 4-year average of 5100.58% and a median of 4472.7% in 2022 frame the typical range for FCF Margin.
- The widest YoY moves for FCF Margin: up 581713 bps in 2023, down 1575764 bps in 2023.
- Over 4 years, FCF Margin stood at 5779.79% in 2022, then soared by 101 bps to 37.34% in 2023, then plunged by 9112 bps to 3365.07% in 2025, then slumped by 36 bps to 4569.83% in 2026.
- According to Business Quant data, FCF Margin over the past three periods registered 4569.83%, 3365.07%, and 626.21% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.41 Bn | 130.56 Bn | 2.84 Bn | 30.39% |
| 2 | Regeneron Pharmaceuticals | 86.12 Bn | 78.12 Bn | 3.93 Bn | 13.35% |
| 3 | Argenx Se | 64.41 Bn | 59.23 Bn | 1.37 Bn | - |
| 4 | Moderna | 57.56 Bn | 52.43 Bn | 52.00 Mn | -388.28% |
| 5 | BeOne Medicines | 42.06 Bn | 36.96 Bn | 1.53 Bn | 25.68% |
| 6 | Alnylam Pharmaceuticals | 30.95 Bn | 27.65 Bn | 992.69 Mn | 22.62% |
| 7 | BioNTech SE | 27.48 Bn | 9.09 Bn | 668.28 Mn | 41.07% |
| 8 | Insmed | 27.31 Bn | 26.15 Bn | 358.27 Mn | -22.35% |
| 9 | Royalty Pharma | 27.04 Bn | 26.20 Bn | - | 70.82% |
| 10 | Seres Therapeutics | 43.87 Mn | 43.87 Mn | - | -3,042.66% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -3,042.66% |
| Mar 31, 2026 | -4,569.83% |
| Dec 31, 2025 | -3,365.07% |
| Sep 30, 2025 | 626.21% |
| Dec 31, 2023 | 37.34% |
| Sep 30, 2023 | -17,523.87% |
| Jun 30, 2023 | 48.71% |
| Mar 31, 2023 | -14,849.04% |
| Dec 31, 2022 | -5,779.79% |
| Sep 30, 2022 | -1,766.23% |
| Jun 30, 2022 | -4,472.70% |
| Mar 31, 2022 | -4,492.10% |
| Dec 31, 2021 | -725.95% |
| Sep 30, 2021 | 101.03% |
| Jun 30, 2021 | -760.65% |
| Mar 31, 2021 | -640.36% |
| Dec 31, 2020 | -1,540.89% |
| Sep 30, 2020 | -1,846.51% |
| Jun 30, 2020 | -492.88% |
| Mar 31, 2020 | -445.29% |